A
33.21
0.07 (0.21%)
| 前收盘价格 | 33.14 |
| 收盘价格 | 33.16 |
| 成交量 | 3,733,222 |
| 平均成交量 (3个月) | 3,412,650 |
| 市值 | 4,131,091,456 |
| 价格/销量 (P/S) | 5.96 |
| 股市价格/股市净资产 (P/B) | 18.17 |
| 52周波幅 | |
| 利润日期 | 25 Feb 2025 - 3 Mar 2025 |
| 营业毛利率 | -34.97% |
| 营业利益率 (TTM) | -24.02% |
| 稀释每股收益 (EPS TTM) | -2.03 |
| 季度收入增长率 (YOY) | 78.30% |
| 总债务/股东权益 (D/E MRQ) | 198.40% |
| 流动比率 (MRQ) | 4.36 |
| 营业现金流 (OCF TTM) | -205.10 M |
| 杠杆自由现金流 (LFCF TTM) | -140.21 M |
| 资产报酬率 (ROA TTM) | -16.23% |
| 股东权益报酬率 (ROE TTM) | -106.56% |
市场趋势
| 短期 | 中期 | ||
| 行业 | Biotechnology (US) | 混合的 | 混合的 |
| Biotechnology (全球的) | 混合的 | 混合的 | |
| 股票 | Apellis Pharmaceuticals, Inc. | 看跌 | 看跌 |
AIStockmoo 评分
-0.6
| 分析师共识 | -0.5 |
| 内部交易活动 | -1.5 |
| 价格波动 | 1.0 |
| 技术平均移动指标 | -2.5 |
| 技术振荡指标 | 0.5 |
| 平均 | -0.60 |
|
Apellis Pharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the discovery, development and commercialization of novel therapeutic compounds to treat diseases with high unmet needs through the inhibition of the complement system, which is an integral component of the immune system, at the level of C3, the central protein in the complement cascade. |
|
| 部门 | Healthcare |
| 行业 | Biotechnology |
| 投资方式 | Small Growth |
| 内部持股比例 | 13.98% |
| 机构持股比例 | 99.14% |
| 52周波幅 | ||
| 目标价格波幅 | ||
| 高 | 60.00 (Needham, 80.67%) | 购买 |
| 中 | 38.00 (14.42%) | |
| 低 | 24.00 (RBC Capital, -27.73%) | 保留 |
| 平均值 | 40.85 (23.01%) | |
| 总计 | 6 购买, 7 保留 | |
| 平均价格@调整类型 | 29.08 | |
| 公司 | 日期 | 目标价格 | 调整类型 | 价格@调整类型 |
|---|---|---|---|---|
| Goldman Sachs | 17 Dec 2024 | 36.00 (8.40%) | 保留 | 34.53 |
| 06 Nov 2024 | 36.00 (8.40%) | 购买 | 28.83 | |
| Morgan Stanley | 21 Nov 2024 | 31.00 (-6.65%) | 保留 | 27.75 |
| Baird | 07 Nov 2024 | 55.00 (65.61%) | 购买 | 28.74 |
| B of A Securities | 06 Nov 2024 | 47.00 (41.52%) | 购买 | 28.83 |
| Citigroup | 06 Nov 2024 | 51.00 (53.57%) | 购买 | 28.83 |
| HC Wainwright & Co. | 06 Nov 2024 | 57.00 (71.64%) | 购买 | 28.83 |
| Needham | 06 Nov 2024 | 60.00 (80.67%) | 购买 | 28.83 |
| Oppenheimer | 06 Nov 2024 | 40.00 (20.45%) | 购买 | 28.83 |
| Piper Sandler | 06 Nov 2024 | 32.00 (-3.64%) | 保留 | 28.83 |
| RBC Capital | 06 Nov 2024 | 24.00 (-27.73%) | 保留 | 28.83 |
| 04 Nov 2024 | 25.00 (-24.72%) | 保留 | 28.56 | |
| Scotiabank | 06 Nov 2024 | 30.00 (-9.67%) | 保留 | 28.83 |
| 16 Oct 2024 | 35.00 (5.39%) | 保留 | 27.95 | |
| Wells Fargo | 06 Nov 2024 | 30.00 (-9.67%) | 保留 | 28.83 |
| Mizuho | 24 Oct 2024 | 38.00 (14.42%) | 保留 | 27.58 |
| 显示更多 | ||||
该时间范围内无数据。
支撑、阻力和趋势线水平是由人工智能（AI）模型生成的，请谨慎解读。
投资组合